tiprankstipranks
Advertisement
Advertisement

DMAC Stock Latest News

DiaMedica Therapeutics announces dosing of first two patients in DM199 study
The FlyDiaMedica Therapeutics announces dosing of first two patients in DM199 study
10d ago
DMAC
DiaMedica Therapeutics receives written response from FDA on DM199
PremiumThe Fly
DiaMedica Therapeutics receives written response from FDA on DM199
17d ago
DMAC
DiaMedica Shareholders Approve Governance, Compensation and Incentive Plan
PremiumCompany Announcements
DiaMedica Shareholders Approve Governance, Compensation and Incentive Plan
1M ago
8K
DMAC
DiaMedica announces 75% enrollment milestone in ReMEDy2 Phase 2/3 trial
PremiumThe Fly
DiaMedica announces 75% enrollment milestone in ReMEDy2 Phase 2/3 trial
1M ago
DMAC
DiaMedica Therapeutics Charts Costly Path to Key Trials
PremiumCompany Announcements
DiaMedica Therapeutics Charts Costly Path to Key Trials
2M ago
DMAC
DiaMedica Therapeutics reports Q1 EPS (19c), consensus (19c)
PremiumThe FlyDiaMedica Therapeutics reports Q1 EPS (19c), consensus (19c)
2M ago
DMAC
DiaMedica sees cash, equivalents funding operations through 2027
Premium
The Fly
DiaMedica sees cash, equivalents funding operations through 2027
2M ago
DMAC
DiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks
Premium
Company Announcements
DiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks
3M ago
DMAC
DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update
PremiumCompany Announcements
DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update
3M ago
DMAC
DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)
PremiumThe Fly
DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)
3M ago
DMAC
DMAC Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
DMAC Upcoming Earnings Report: What to Expect?
3M ago
DMAC
DiaMedica Therapeutics receives Health Canada clearance to initiate DM199 study
PremiumThe Fly
DiaMedica Therapeutics receives Health Canada clearance to initiate DM199 study
4M ago
DMAC
Omega takes new stake in Rocket Companies, exits ArriVent Biopharma
PremiumThe FlyOmega takes new stake in Rocket Companies, exits ArriVent Biopharma
5M ago
ET
ABR
DiaMedica Therapeutics Raises Capital via Share Offering
Premium
Company Announcements
DiaMedica Therapeutics Raises Capital via Share Offering
6M ago
8K
DMAC
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
Premium
The Fly
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
6M ago
DMAC
DiaMedica Therapeutics provides DM199 update following FDA meeting
PremiumThe Fly
DiaMedica Therapeutics provides DM199 update following FDA meeting
7M ago
DMAC
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
PremiumCompany Announcements
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
7M ago
DMAC
Buy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress
PremiumRatings
Buy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress
8M ago
DMAC
Microsoft initiated, Home Depot downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Microsoft initiated, Home Depot downgraded: Wall Street’s top analyst calls
8M ago
HD
MP
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
8M ago
DMAC
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
8M ago
DMAC
DiaMedica Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
DiaMedica Therapeutics Reports Q3 2025 Financial Results
8M ago
DMAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >